0 Σχόλια
0 Μοιράστηκε
1χλμ. Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Breast Cancer Liquid Biopsy Market: Business Applications and Industry PrioritiesBreast Cancer Liquid Biopsy Market Projected to Reach USD 2,700.76 Million by 2034 Polaris Market Research reports that the breast cancer liquid biopsy market was valued at USD 494.42 million in 2025. The 2026 estimate is USD 596.21 Million, and the market is projected to reach USD 2,700.76 Million by 2034, representing a 20.8% compound annual growth rate during 2026–2034. The outlook...0 Σχόλια 0 Μοιράστηκε 121 Views 0 Προεπισκόπηση
-
Circulating Tumor Cells Cancer Stem Cells Market – Liquid Biopsy Innovation Advancing Precision OncologyMarket Overview The circulating tumor cells cancer stem cells market is expanding as liquid biopsy technology gains traction for non-invasive cancer detection, monitoring, and treatment response assessment. By isolating and analyzing rare tumor cells circulating in a patient's bloodstream, clinicians can gather valuable information about cancer progression without invasive tissue biopsies....0 Σχόλια 0 Μοιράστηκε 713 Views 0 Προεπισκόπηση
-
Exosome Diagnostic and Therapeutics Market – Extracellular Vesicles Advancing Liquid Biopsy ScienceMarket Overview The exosome diagnostic and therapeutics market is expanding as researchers increasingly recognize extracellular vesicles as valuable carriers of biomarker information and potential therapeutic delivery vehicles. Exosomes shed by cells into biological fluids carry proteins, nucleic acids, and lipids reflecting their cell of origin, making them attractive candidates for...0 Σχόλια 0 Μοιράστηκε 569 Views 0 Προεπισκόπηση
-
Liquid Biopsy Breakthroughs Drive Circulating Tumor Cells Market to USD 45.13 Billion by 2034Cancer spreads when tumor cells break away from the original tumor, travel through the bloodstream and settle in other parts of the body. Detecting these cells in a simple blood sample offers a powerful window into how a cancer is behaving. This idea sits at the heart of liquid biopsy, a fast-growing field that aims to diagnose, monitor and guide treatment of cancer without the need for...0 Σχόλια 0 Μοιράστηκε 106 Views 0 Προεπισκόπηση
-
Liquid Biopsy ctDNA Monitoring and Early Molecular Screening in Esophageal Cancer ManagementUtilizing non-invasive circulating tumor DNA (ctDNA) tracking and advanced molecular diagnostics is modernizing post-treatment surveillance in esophageal oncology. Detailed analysis within the Esophageal Cancer Market report reveals how liquid biopsy assays detect minimal residual disease (MRD) months before anatomical recurrence appears on CT or PET scans. Serial blood monitoring allows...0 Σχόλια 0 Μοιράστηκε 350 Views 0 Προεπισκόπηση
-
Liquid Biopsy Market Analysis: Size, Share, Segments & ForecastThe Liquid Biopsy Market is covered by Business Market Insights with 2025 as the base year and 2026–2033 as the forecast period. The Liquid Biopsy Market size was valued at US$ 11.94 Billion in 2025 and is projected to reach US$ 94.29 Billion by 2033, growing at a CAGR of 29.47% during 2026–2033. Market growth is best understood through customer demand, operating economics, and...0 Σχόλια 0 Μοιράστηκε 102 Views 0 Προεπισκόπηση
-
Liquid Biopsy Market Role in Personalized and Targeted Cancer Treatment 2031The Liquid Biopsy Market is gaining importance in treatment monitoring. Repeated blood-based testing can potentially provide information about changes in tumor biology without requiring repeated invasive tissue procedures. The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering an estimated CAGR of 11.2% through 2031....0 Σχόλια 0 Μοιράστηκε 398 Views 0 Προεπισκόπηση
-
Liquid Biopsy Market to Reach USD 29.2 Billion by 2036 as Precision Oncology and Non-Invasive Cancer Testing Drive Global GrowthThe global Liquid Biopsy Market is poised for substantial expansion as healthcare providers increasingly adopt minimally invasive cancer diagnostic technologies for early detection, treatment monitoring, and personalized medicine. According to the latest industry analysis, the global Liquid Biopsy Market is projected to grow from USD 7.3 billion in 2026 to USD 29.2 billion by 2036, registering...0 Σχόλια 0 Μοιράστηκε 773 Views 0 Προεπισκόπηση
-
Liquid Biopsy Market Value, Demand and Competitive Industry InsightsLiquid biopsy has emerged as a transformative technology in modern oncology and precision medicine. The growing demand for non-invasive diagnostic techniques, rising prevalence of cancer worldwide, and increasing adoption of personalized medicine are significantly contributing to market growth. Liquid biopsy enables the detection of cancer biomarkers through blood samples, eliminating the need...0 Σχόλια 0 Μοιράστηκε 2χλμ. Views 0 Προεπισκόπηση
-
Liquid Tumor Biopsy Market Driven By Non Invasive Diagnostic SolutionsThe Liquid Tumor Biopsy Market growth continues to accelerate as precision oncology increasingly shifts toward non-invasive, real-time monitoring of cancer progression and treatment response. With rising global cancer incidence and growing demand for alternatives to traditional tissue biopsies—which are often invasive, painful, and geographically constrained—the adoption of...0 Σχόλια 0 Μοιράστηκε 635 Views 0 Προεπισκόπηση
-
The Growing Role of Liquid Biopsy Diagnostics in Non-Invasive Cancer DetectionThe field of oncology diagnostics has been revolutionized by the development of liquid biopsy technologies, which offer a non-invasive alternative to traditional tissue biopsies. Liquid biopsy diagnostics analyze circulating tumor cells, cell-free DNA, and other biomarkers found in bodily fluids, enabling early cancer detection and monitoring. The In Vitro Diagnostic Liquid Biopsy Testing...0 Σχόλια 0 Μοιράστηκε 479 Views 0 Προεπισκόπηση
-
Companion Diagnostics Market Growth Through Biomarker-Guided TreatmentThe companion diagnostics market is becoming an increasingly important link between diagnosis and treatment. Instead of asking only whether a disease is present, modern healthcare is increasingly asking a more specific question: which therapy is most appropriate for this patient? That change is reshaping the role of diagnostics. A biomarker can now influence whether a targeted drug is...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Pancreatic Cancer Diagnostic Market Growth Driven by Advanced Testing TechnologiesThe pancreatic cancer diagnostic market is entering a period of technological transformation as healthcare providers seek more reliable ways to identify one of the deadliest forms of cancer. With many patients diagnosed only after the disease has advanced, the need for earlier detection, improved diagnostic accuracy, and accessible testing solutions is becoming increasingly important. The...0 Σχόλια 0 Μοιράστηκε 759 Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)